CNR2 and cancer: Michalski et al. found that cannabinoid-1 receptor (CB1) and CB2 were expressed more strongly in PDAC cells than in normal pancreatic cells, and a survival analysis indicated that a low expression of CB1 in cancer cells was associated with better outcomes, while low levels of cannabinoid-metabolizing enzymes in cancer cells shortened survival [22].